Saturday Edition
Stay updated with Archyde – your source for breaking news, global headlines, economy, entertainment, health, technology, and sports. Fresh stories daily.
Incretin-based therapies, specifically GLP-1 receptor agonists, are fundamentally shifting the clinical management of obesity and type 2 diabetes. By mimicking hormones that regulate appetite and glycemic control, these injectable medications ... Read More
Continuous Coverage
Google’s pricing strategy for the Pixel 11, unveiled this July 2026, confirms a calculated shift in the company’s…
Amphastar Pharmaceuticals (NASDAQ:AMPH) is currently positioned as a high-quality investment due to its strong profitability, 15.12% return on…
DC Comics’ October 2024 DC Direct catalogue has surged to a $60 resale value on the secondary market,…
A 48-year-old youth volleyball coach in California’s East Bay was arrested by the Pleasanton Police Department on suspicion…
Public concern over the environmental footprint of data centers in Canada is rising, with a recent CityNews Toronto…
A new dietitian-designed, 7-day high-protein, high-fiber meal plan offers a structured approach to improving metabolic health and satiety.…
Global Affairs
Zelenskyy Weighs Military Shake-up Amid Growing Internal Friction This potential restructuring, coupled with public protests in Kyiv, reflects…
Markets And Money
South Korean banking institutions, including KB Financial Group (KRX: 105560) and Shinhan Financial Group (KRX: 055550), are demonstrating…
Digital Culture
Samsung has confirmed it will host a Galaxy Unpacked event in London on Wednesday, July 22, 2026, to…
Science And Wellbeing
The dedication of researchers and advocates facing terminal illness often leaves a profound legacy. While many individuals diagnosed…
Screen And Sound
A popular K-pop idol, currently fulfilling their mandatory military service, broke down in tears during a recent military…
Fixtures And Form
Singapore has transformed the World Cup final into a national event, with mosques, churches, and schools hosting public…
